Robuta

https://www.oncotarget.com/ Peer-reviewed Oncology & Cancer Research Journal | Oncotarget Oncotarget is a peer-reviewed, open-access oncology journal indexed in PubMed/MEDLINE and Scopus. Publishing cutting-edge cancer research since 2010. ISSN:... peer reviewedcancer researchoncologyjournaloncotarget https://www.oncotarget.org/misha-blagosklonny/ Misha Blagosklonny | Oncotarget.org | cancer, rapamycin, aging, hyperfunction theory, immortality May 13, 2025 - Misha Blagosklonny, M.D., Ph.D. is a founder and Editor-in-Chief at Oncotarget and Aging, an Editor-in-Chief at Oncoscience, and an editor at Genes and Cancer.... mishaoncotargetcancerrapamycinaging https://www.brightsurf.com/news/8OM03DN1/oncotarget-polyisoprenylated-cysteinyl-amide-inhibitors-deplete-g-proteins-in-cancer-cells.html Oncotarget | Polyisoprenylated cysteinyl amide inhibitors deplete g-proteins in cancer cells |... Researchers found significant decreases in the levels of KRAS, RHOA, RAC1, and CDC42 after PCAI treatment, implicating their role in cancer progression and... in canceroncotargetinhibitorsdepleteproteins https://ecancer.org/en/news/18873-oncotarget-th1-cytokines-potentiate-apoptosis-of-breast-cancer-cells-and-suppress-tumour-growth Oncotarget: Th1 cytokines potentiate apoptosis of breast cancer cells and suppress tumour growth -... Volume 11, Issue 30 of Oncotarget reported that previously, the authors showed that anti-estrogen drugs combined with a dendritic cell-based anti-HER-2 vacci breast canceroncotargetcytokinespotentiateapoptosis https://bioweb.supagro.inrae.fr/ESTHER/paper/Choi_2016_Oncotarget_7_75319 Choi_2016_Oncotarget_7_75319 choioncotarget